SCM
PFE icon

Shapiro Capital Management’s Pfizer PFE Stock Holding History

Shapiro Capital Management’s Portfolio PFE Stock Details PFE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q2 		– Sell
-6,566
Closed -$340K – 79
2022
Q1 		$340K Sell
6,566
-290
-4% -$15K 0.01% 70
2021
Q4 		$405K Sell
6,856
-676,677
-99% -$33.5M 0.01% 66
2021
Q3 		$29.4M Sell
683,533
-3,000,606
-81% -$133M 0.55% 40
2021
Q2 		$144M Buy
3,684,139
+90,396
+3% +$3.52M 2.51% 17
2021
Q1 		$130M Buy
3,593,743
+237,653
+7% +$8.44M 2.37% 19
2020
Q4 		$124M Sell
3,356,090
-139,475
-4% -$5.12M 2.66% 14
2020
Q3 		$122M Buy
3,495,565
+142,194
+4% +$4.99M 3.34% 8
2020
Q2 		$104M Sell
3,353,371
-129,985
-4% -$4.42M 2.97% 11
2020
Q1 		$108M Buy
+3,483,356
New +$119M 3.67% 8
2018
Q4 		– Sell
-2,562,734
Closed -$107M – 87
2018
Q3 		$107M Sell
2,562,734
-113,140
-4% -$4.36M 2.27% 22
2018
Q2 		$92.1M Buy
2,675,874
+23,592
+0.9% +$806K 2% 27
2018
Q1 		$89.3M Buy
2,652,282
+921
+0% +$31.7K 2.09% 22
2017
Q4 		$91.1M Sell
2,651,361
-80,335
-3% -$2.74M 1.99% 27
2017
Q3 		$92.5M Sell
2,731,696
-60,538
-2% -$1.95M 2.1% 21
2017
Q2 		$89M Buy
2,792,234
+154,352
+6% +$4.87M 2.16% 19
2017
Q1 		$85.6M Buy
+2,637,882
New +$83.2M 2.05% 21
2016
Q1 		– Sell
-4,169,143
Closed -$128M – 70
2015
Q4 		$128M Buy
4,169,143
+955,508
+30% +$30.1M 3.73% 6
2015
Q3 		$95.8M Sell
3,213,635
-63,307
-2% -$2.03M 2.87% 14
2015
Q2 		$104M Sell
3,276,942
-927,808
-22% -$30.2M 2.54% 16
2015
Q1 		$139M Sell
4,204,750
-53,362
-1% -$1.7M 3.45% 13
2014
Q4 		$126M Sell
4,258,112
-62,250
-1% -$1.78M 3.11% 12
2014
Q3 		$121M Buy
4,320,362
+533,142
+14% +$15M 3.17% 15
2014
Q2 		$107M Buy
3,787,220
+456,044
+14% +$13M 2.58% 18
2014
Q1 		$102M Buy
3,331,176
+450,867
+16% +$13.4M 2.69% 17
2013
Q4 		$83.7M Buy
2,880,309
+145,124
+5% +$4.22M 2.19% 22
2013
Q3 		$74.5M Buy
2,735,185
+219,233
+9% +$5.97M 2.11% 24
2013
Q2 		$66.9M Buy
+2,515,952
New +$69.5M 2.09% 23

Other funds holding PFE

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return
Charles Schwab
Charles Schwab San Francisco, California $654B AUM 26.35% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Shapiro Capital Management's PFE Position: Q2 2022 in Review

Shapiro Capital Management sold out of Pfizer (PFE) in Q2 2022, closing a stake of 6,566 shares — an estimated $340K sold.

Shapiro Capital Management first reported a position in PFE in Q2 2013 and held it in 27 quarters. The position peaked at $144M in Q2 2021. 3,158 funds tracked by Wall St. Rank hold PFE as of Q2 2022.

  • Shapiro Capital Management reported no remaining Pfizer position as of Q2 2022 after selling out during the quarter.
  • Shapiro Capital Management sold 6,566 Pfizer shares in Q2 2022, an estimated $340K.
  • Shapiro Capital Management first reported a position in Pfizer in Q2 2013 and held it in 27 quarters.
  • Shapiro Capital Management's Pfizer position peaked at $144M in Q2 2021.
  • 3,158 funds tracked by Wall St. Rank held Pfizer as of Q2 2022.

Based on Shapiro Capital Management's 13F filing for Q2 2022, filed 12 Aug 2022.